Strive, Inc. Acquires Semler Scientific in Stock Deal

Strive, Inc. has agreed to acquire Semler Scientific, Inc. in an all-stock transaction and purchased 5,816 Bitcoins for $675 million, totaling 5,886 BTC in holdings.

This acquisition signals a strategic expansion in Bitcoin treasury and diagnostics, potentially influencing corporate treasury strategies and impacting Bitcoin’s market value.

Strive’s Strategic Bitcoin Acquisition Moves

Strive, Inc. has signed a definitive agreement to acquire Semler Scientific in an all-stock transaction. The signing reflects a unified decision by the boards of both companies, with Semler’s Executive Chairman Eric Semler joining Strive’s board.

The acquisition includes Strive’s purchase of 5,816 Bitcoins for $675 million. This move significantly enhances its total Bitcoin holding to 5,886 BTC, aiming above 10,900 upon completing the ongoing merger and future financing activities.

“The acquisition of Semler Scientific will significantly enhance our strategic capabilities, especially in the realm of fintech innovations,” said Eric Semler, Executive Chairman, Semler Scientific, Inc.

Market reactions remain cautiously optimistic as stakeholders anticipate the monetization or distribution of Semler’s profitable diagnostics business. While explicit government or industry statements were missing, investor interest in Strive’s Bitcoin strategy appears sustained.

Bitcoin Market Dynamics and Future Outlook

Did you know? When MicroStrategy Inc. first adopted a Bitcoin treasury strategy, it substantially influenced corporate Bitcoin purchasing trends, much like Strive’s current approach.

As of September 22, 2025, Bitcoin (BTC) is priced at $112,673.55 with a market cap of formatNumber(2244828586336.11, 2). Its 24-hour trading volume rose by 140.16%, reaching $53,902,458,065.72. Price adjustments over various durations include a drop of 2.70% in the last day and a quarterly growth of 7.21%, per CoinMarketCap.

The Coincu research team emphasizes that combining Bitcoin holdings with a profitable diagnostics division presents both financial and operational opportunities. They suggest focal areas of scrutiny due to macroeconomic volatility and regulatory standards. These elements can potentially shape future market dynamics and investor behavior.